Experimental and clinical aspects of melatonin and clock genes in diabetes
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
The pineal hormone melatonin influences insulin secretion, as well as glucagon and somatostatin secretion, both in vivo and in vitro. These effects are mediated by two specific, high‐affinity, seven transmembrane, pertussis toxin‐sensitive, Gi‐protein‐coupled melatonin receptors, MT 1 and MT 2. Both isoforms are expressed in the β‐cells, α‐cells as well as δ‐cells of the pancreatic islets of Langerhans and are involved in the modulation of insulin secretion, leading to inhibition of the adenylate cyclase‐dependent cyclic adenosine monophosphate as well as cyclic guanosine monophosphate formation in pancreatic β‐cells by inhibiting the soluble guanylate cyclase, probably via MT 2 receptors. In this way, melatonin also likely inhibits insulin secretion, whereas using the inositol triphosphate pathway after previous blocking of Gi‐proteins by pertussis toxin, melatonin increases insulin secretion. Desynchrony of receptor signaling may lead to the development of type 2 diabetes. This notion has recently been supported by genomewide association studies pinpointing variances of the MT 2 receptor as a risk factor for this rapidly spreading metabolic disturbance. As melatonin is secreted in a clearly diurnal fashion, it is safe to assume that it also has a diurnal impact on the blood‐glucose‐regulating function of the islet. Observations of the circadian expression of clock genes (Clock, Bmal1, Per1,2,3, and Cry1,2) in pancreatic islets, as well as in INS 1 rat insulinoma cells, may indicate that circadian rhythms are generated in the β‐cells themselves. The circadian secretion of insulin from pancreatic islets is clock‐driven. Disruption of circadian rhythms and clock function leads to metabolic disturbances, for example, type 2 diabetes. The study of melatonin–insulin interactions in diabetic rat models has revealed an inverse relationship between these two hormones. Both type 2 diabetic rats and patients exhibit decreased melatonin levels and slightly increased insulin levels, whereas type 1 diabetic rats show extremely reduced levels or the absence of insulin, but statistically significant increases in melatonin levels. Briefly, an increase in melatonin levels leads to a decrease in stimulated insulin secretion and vice versa. Melatonin levels in blood plasma, as well as the activity of the key enzyme of melatonin synthesis, AA‐NAT (arylalkylamine‐N‐acetyltransferase) in pineal, are lower in type 2 diabetic rats compared to controls. In contrast, melatonin and pineal AA‐NAT m RNA are increased and insulin receptor m RNA is decreased in type 1 diabetic rats, which also indicates a close relationship between insulin and melatonin. As an explanation, it was hypothesized that catecholamines, which reduce insulin levels and stimulate melatonin synthesis, control insulin–melatonin interactions. This conviction stems from the observation that catecholamines are increased in type 1 but are diminished in type 2 diabetes. In this context, another important line of inquiry involves the fact that melatonin protects β‐cells against functional overcharge and, consequently, hinders the development of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coordination of circadian timing in mammals
Reppert, S. M., & Weaver, D. R. (2002) · Nature · doi:10.1038/nature00965 · Cited by 4,379
Obesity and Metabolic Syndrome in Circadian Clock Mutant Mice
Turek, F. W., Joshu, C., Kohsaka, A., Lin, E., Ivanova, G., McDearmon, E., Laposky, A., Losee-Olson, S., Easton, A., Jensen, D. R., et al. (2005) · Science · doi:10.1126/science.1108750 · Cited by 2,485 · cited 1×
“A study of homozygous Clock / mutant mice confirmed that the proper regulation of their metabolism is strictly dependent on the unperturbed function of the circadian clock [103].”
BackgroundDibner, C., Schibler, U., & Albrecht, U. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135821 · Cited by 2,421
Damiola, F., Le Minh, N., Preitner, N., Kornmann, B., Fleury-Olela, F., & Schibler, U. (2000) · Genes & Development · doi:10.1101/gad.183500 · Cited by 2,394 · cited 1×
“By restricting access to food for a few hours during the light phase, researchers were able to totally uncouple the peripheral clocks of liver and pancreas from the dominance of the SCN and even to invert the circadian rhythm of the peripheral clocks [60, 96].”
BackgroundAdverse metabolic and cardiovascular consequences of circadian misalignment
Scheer, F. A. J. L., Hilton, M. F., Mantzoros, C. S., & Shea, S. A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808180106 · Cited by 2,351
Entrainment of the circadian clock in the liver by feeding
Stokkan, K.-A., Yamazaki, S., Tei, H., Sakaki, Y., & Menaker, M. (2001) · Science · doi:10.1126/science.291.5503.490 · Cited by 1,800 · cited 18×
“By restricting access to food for a few hours during the light phase, researchers were able to totally uncouple the peripheral clocks of liver and pancreas from the dominance of the SCN and even to invert the circadian rhythm of the peripheral clocks [60, 96].”
BackgroundInfluentialDisruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes
Marcheva, B., Ramsey, K. M., Buhr, E. D., Kobayashi, Y., Su, H., Ko, C. H., Ivanova, G., Omura, C., Mo, S., Vitaterna, M. H., et al. (2010) · Nature · doi:10.1038/nature09253 · Cited by 1,525
The unique cytoarchitecture of human pancreatic islets has implications for islet cell function
Cabrera, O., Berman, D. M., Kenyon, N. S., Ricordi, C., Berggren, P.-O., & Caicedo, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510790103 · Cited by 1,312
Circadian Control of the NAD + Salvage Pathway by CLOCK-SIRT1
Nakahata, Y., Sahar, S., Astarita, G., Kaluzova, M., & Sassone-Corsi, P. (2009) · Science · doi:10.1126/science.1170803 · Cited by 1,198
Reppert, S. M., Weaver, D. R., & Ebisawa, T. (1994) · Neuron · doi:10.1016/0896-6273(94)90055-8 · Cited by 1,096 · cited 10×
“Thus, the data demonstrate the existence of the melatonin membrane receptors MT1 and MT2 in human pancreatic tissue and that these receptors show upregulated expression levels in type 2 diabetic patients [66].”
BackgroundInfluentialRudic, R. D., McNamara, P., Curtis, A.-M., Boston, R. C., Panda, S., Hogenesch, J. B., & FitzGerald, G. A. (2004) · PLoS Biology · doi:10.1371/journal.pbio.0020377 · Cited by 1,059 · cited 2×
“For example, analysis of Clock and Bmal1 / mice demonstrated that gluconeogenesis was impaired in Clock mutant mice [102].”
BackgroundRegulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors
Rutter, J., Reick, M., Wu, L. C., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1060698 · Cited by 1,059
Physiological significance of a peripheral tissue circadian clock
Lamia, K. A., Storch, K.-F., & Weitz, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806717105 · Cited by 1,048 · cited 2×
“[104] employed a mouse line with a liver-specific deletion of Bmal1, in addition to a systemic homozygous Bmal1 / line, in order to analyze glucose homeostasis.”
BackgroundMethodAssociation of sleep time with diabetes mellitus and impaired glucose tolerance
Gottlieb, D. J., Punjabi, N. M., Newman, A. B., Resnick, H. E., Redline, S., Baldwin, C. M., & Nieto, F. J. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.863 · Cited by 927
Slow-wave sleep and the risk of type 2 diabetes in humans
Tasali, E., Leproult, R., Ehrmann, D. A., & Van Cauter, E. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706446105 · Cited by 921 · cited 1×
“Sleeping disturbances leading to a disruption in melatonin synthesis have therefore been linked to pathologically altered insulin secretion and diabetes [113, 125].”
BackgroundHypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes.
Cryer, P. (2002) · Diabetologia · doi:10.1007/s00125-002-0822-9 · Cited by 794
Sleep duration as a risk factor for the development of type 2 diabetes
Yaggi, H. K., Araujo, A. B., & McKinlay, J. B. (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-0879 · Cited by 790
Lyssenko, V., Nagorny, C. L. F., Erdos, M. R., Wierup, N., Jonsson, A., Spégel, P., Bugliani, M., Saxena, R., Fex, M., Pulizzi, N., et al. (2009) · Nature Genetics · doi:10.1038/ng.288 · Cited by 742 · cited 7×
“9 cell line, studies on human pancreatic islets have demonstrated that both MT1 and MT2 melatonin receptors are expressed, although they are primarily detected in b-cells [117].”
BackgroundResultInfluentialSimonneaux, V., & Ribelayga, C. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.2.2 · Cited by 740 · cited 3×
“Concerning noradrenergic a2 receptors, it is well known that, when these adrenergic receptors are expressed, noradrenaline can act either through the autoreceptors of the nerve terminals suppressing its release or through this receptor expressed on the pinealocytes [185].”
BackgroundSIRT1 Mediates Central Circadian Control in the SCN by a Mechanism that Decays with Aging
Chang, H.-C., & Guarente, L. (2013) · Cell · doi:10.1016/j.cell.2013.05.027 · Cited by 615
Bouatia-Naji, N., Bonnefond, A., Cavalcanti-Proença, C., Sparsø, T., Holmkvist, J., Marchand, M., Delplanque, J., Lobbens, S., Rocheleau, G., Durand, E., et al. (2009) · Nature Genetics · doi:10.1038/ng.277 · Cited by 611 · cited 3×
“One of the loci with a high and reproducible association with a higher risk of impaired insulin secretion and increased fasting-glucose levels is represented by the gene for the MT2 receptor (MTNR1B), or, more specifically, by some of the common genetic variants (single nucleotide polymorphisms, SNPs) thereof [117, 11…”
BackgroundResultDiminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus
Ward, W. K., Bolgiano, D. C., McKnight, B., Halter, J. B., & Porte, D. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111542 · Cited by 483
Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep
Van Cauter, E., Blackman, J. D., Roland, D., Spire, J. P., Refetoff, S., & Polonsky, K. S. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115396 · Cited by 448
Donga, E., van Dijk, M., van Dijk, J. G., Biermasz, N. R., Lammers, G.-J., van Kralingen, K. W., Corssmit, E. P. M., & Romijn, J. A. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2430 · Cited by 387
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes
The Meta-Analysis of Glucose and Insulin-Related Traits Consortium (MAGIC), Bonnefond, A., Clément, N., Fawcett, K., Yengo, L., Vaillant, E., Guillaume, J.-L., Dechaume, A., Payne, F., Roussel, R., et al. (2012) · Nature Genetics · doi:10.1038/ng.1053 · Cited by 363
Sadacca, L. A., Lamia, K. A., deLemos, A. S., Blum, B., & Weitz, C. J. (2011) · Diabetologia · doi:10.1007/s00125-010-1920-8 · Cited by 314 · cited 1×
“A recent paper [93] proved evidence that a functional circadian clock is essential for islet functions and glucose homeostasis.”
BackgroundMelatonin, endocrine pancreas and diabetes
Peschke, E. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00519.x · Cited by 309
Self-citationGale, J. E., Cox, H. I., Qian, J., Block, G. D., Colwell, C. S., & Matveyenko, A. V. (2011) · Journal of Biological Rhythms · doi:10.1177/0748730411416341 · Cited by 247 · cited 1×
“In contrast to the aforementioned reports on diverse mouse knockout models, research on a type 2 diabetic-prone rat model, the amyloid polypeptide transgenic (HIP) rat, has also been carried out [108].”
ResultThe effects of nocturnal life on endocrine circadian patterns in healthy adults
Qin, L.-Q., Li, J., Wang, Y., Wang, J., Xu, J.-Y., & Kaneko, T. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00628-3 · Cited by 192 · cited 1×
“The mesor and the amplitude of melatonin are modulated by annual variation, the mesor peaking in winter and the amplitude in summer [219].”
BackgroundRuiter, M., La Fleur, S. E., van Heijningen, C., van der Vliet, J., Kalsbeek, A., & Buijs, R. M. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1709 · Cited by 170
Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene
Mulder, H., Nagorny, C. L. F., Lyssenko, V., & Groop, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1359-y · Cited by 169
Altered postprandial hormone and metabolic responses in a simulated shift work environment
Ribeiro, D., Hampton, S., Morgan, L., Deacon, S., & Arendt, J. (1998) · Journal of Endocrinology · doi:10.1677/joe.0.1580305 · Cited by 155
Evidence for a circadian rhythm of insulin release from perifused rat pancreatic islets
Peschke, E., & Peschke, D. (1998) · Diabetologia · doi:10.1007/s001250051034 · Cited by 150
Self-citationIndication of circadian oscillations in the rat pancreas
Mühlbauer, E., Wolgast, S., Finckh, U., Peschke, D., & Peschke, E. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00322-9 · Cited by 147 · cited 1×
“[89] succeeded in monitoring ex vivo the expression pattern of clock genes in a circadian series of pancreata collected from rats.”
BackgroundSelf-citationCagnacci, A., Arangino, S., Renzi, A., Paoletti, A. M., Melis, G. B., Cagnacci, P., & Volpe, A. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01232.x · Cited by 139 · cited 1×
“However, most authors agree that the pineal gland has a suppressive effect on the activity of the pancreatic insulin-producing b-cell, because melatonin reduces insulin levels [30–32] and glucose tolerance in rats [33, 34].”
BackgroundNew evidence for a role of melatonin in glucose regulation
Peschke, E., & Mühlbauer, E. (2010) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2010.09.001 · Cited by 137
Self-citationKemp, D. M., Ubeda, M., & Habener, J. F. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00064-3 · Cited by 122 · cited 7×
“Shortly thereafter, this line of research was complemented by the detection of melatonin receptor transcripts in the islets of rodent and human pancreas [51, 55], which was further substantiated by immunohistochemical evidence [66].”
BackgroundResultInfluentialSchmid, S. M., Hallschmid, M., Jauch-Chara, K., Bandorf, N., Born, J., & Schultes, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2788 · Cited by 115 · cited 1×
“[158, 159] demonstrated for the first time that both total sleep loss and mild sleep restriction are associated with reduced plasma glucagon concentrations in humans.”
BackgroundRole of SCN in Daily Rhythms of Plasma Glucose, FFA, Insulin and Glucagon
Yamamoto, H., Nagai, K., & Nakagawa, H. (1987) · Chronobiology International · doi:10.3109/07420528709078539 · Cited by 90
Exocytotic Properties of Human Pancreatic β‐cells
Braun, M., Ramracheya, R., Johnson, P. R., & Rorsman, P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2008.03992.x · Cited by 60 · cited 1×
“In rodents, the cAMP acts on the insulin secretion machinery via exchange protein directly activated by cAMP (EPAC), cAMP-regulated guanine nucleotide exchange factor-II (cAMP-GEFII) within the secretory complex [126], and protein kinase A (PKA) associated with the phosphorylation of voltage-gated Ca channels [127], a…”
BackgroundMild Sleep Restriction Acutely Reduces Plasma Glucagon Levels in Healthy Men
Schmid, S. M., Jauch-Chara, K., Hallschmid, M., & Schultes, B. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0969 · Cited by 55 · cited 1×
“[158, 159] demonstrated for the first time that both total sleep loss and mild sleep restriction are associated with reduced plasma glucagon concentrations in humans.”
BackgroundZibolka, J., Mühlbauer, E., & Peschke, E. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12206 · Cited by 21 · cited 1×
“The first data originate from recent papers, published in 2014 and 2015 [169, 170].”
BackgroundSelf-citation
Cited by
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Melatonin as a mitochondria-targeted antioxidant: one of evolution's best ideas
Reiter, R. J., Rosales-Corral, S., Tan, D. X., Jou, M. J., Galano, A., & Xu, B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2609-7 · Cited by 558
Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin
Hosseinzadeh, A., Kamrava, S. K., Joghataei, M. T., Darabi, R., Shakeri‐Zadeh, A., Shahriari, M., Reiter, R. J., Ghaznavi, H., & Mehrzadi, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12362 · Cited by 344
Masci, A., Carradori, S., Casadei, M. A., Paolicelli, P., Petralito, S., Ragno, R., & Cesa, S. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.01.176 · Cited by 299
Cancer metastasis: Mechanisms of inhibition by melatonin
Su, S., Hsieh, M., Yang, W., Chung, W., Reiter, R. J., & Yang, S. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12370 · Cited by 280
Metadata
- Authors
- Peschke, E., Bähr, I., & Mühlbauer, E.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2015-06-06
- Volume
- 59
- Issue
- 1
- Pages
- 1-23
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W2022220021
- Cited by
- 111
- References
- 42
- FWCI
- 7.58
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.